{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:41:09Z","timestamp":1767066069168,"version":"3.41.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01318","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:07:35Z","timestamp":1574813255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Mesothelioma Driver Genes, Ferroptosis, and Therapy"],"prefix":"10.3389","volume":"9","author":[{"given":"Emanuela","family":"Felley-Bosco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.seminoncol.2018.07.005","article-title":"New concepts in follicular lymphoma biology: from BCL2 to epigenetic regulators and non-coding RNAs","volume":"45","author":"Devan","year":"2018","journal-title":"Semin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov."},{"key":"B4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling","volume":"572","author":"Wu","year":"2019","journal-title":"Nature."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell."},{"key":"B7","first-page":"5547","article-title":"p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma","volume":"54","author":"Cheng","year":"1994","journal-title":"Cancer Res."},{"key":"B8","first-page":"511","article-title":"Codeletion of p15 and p16 in primary malignant mesothelioma","volume":"11","author":"Xio","year":"1995","journal-title":"Oncogene."},{"key":"B9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.0.CO;2-2","article-title":"The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma","volume":"75","author":"Prins","year":"1998","journal-title":"Int J Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrm3823","article-title":"Cellular senescence: from physiology to pathology","volume":"15","author":"Munoz-Espin","year":"2014","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.redox.2017.08.015","article-title":"Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis","volume":"14","author":"Masaldan","year":"2018","journal-title":"Redox Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/d41586-019-02218-y","article-title":"Cancer-cell death ironed out","volume":"572","author":"Fennell","year":"2019","journal-title":"Nature."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1038\/s41388-018-0153-z","article-title":"How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations","volume":"37","author":"Rehrauer","year":"2018","journal-title":"Oncogene."},{"key":"B14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.pathol.4.110807.092314","article-title":"Mitochondrial energetics and therapeutics","volume":"5","author":"Wallace","year":"2010","journal-title":"Annu Rev Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","article-title":"The development of the concept of ferroptosis","volume":"133","author":"Hirschhorn","year":"2019","journal-title":"Free Radic Biol Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","article-title":"The oxidative stress-inducible cystine\/glutamate antiporter, system x (c) (-): cystine supplier and beyond","volume":"42","author":"Conrad","year":"2012","journal-title":"Amino Acids."},{"key":"B17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0092-8674(83)90155-1","article-title":"Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture","volume":"34","author":"Connell","year":"1983","journal-title":"Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1158\/1078-0432.CCR-12-0599","article-title":"Role of hedgehog signaling in malignant pleural mesothelioma","volume":"18","author":"Shi","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jcp.1041070215","article-title":"Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol","volume":"107","author":"Ishii","year":"1981","journal-title":"J Cell Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife."},{"key":"B21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41467-019-09307-6","article-title":"Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications","volume":"10","author":"Blum","year":"2019","journal-title":"Nat Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature."},{"key":"B24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.1038\/s41598-019-42251-5","article-title":"Small-molecule ferroptotic agents with potential to selectively target cancer stem cells","volume":"9","author":"Taylor","year":"2019","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1158\/1940-6207.CAPR-13-0244","article-title":"Deferasirox induces mesenchymal-epithelial transition in crocidolite-induced mesothelial carcinogenesis in rats","volume":"6","author":"Nagai","year":"2013","journal-title":"Cancer Prev Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrd.2015.6","article-title":"Regulated necrosis: disease relevance and therapeutic opportunities","volume":"15","author":"Conrad","year":"2016","journal-title":"Nat Rev Drug Discov."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1097\/JTO.0b013e3181ec18db","article-title":"A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307","volume":"5","author":"Dubey","year":"2010","journal-title":"J Thorac Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/JTO.0b013e31828c2b26","article-title":"Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy","volume":"8","author":"Papa","year":"2013","journal-title":"J Thorac Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","article-title":"The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells","volume":"8","author":"Sato","year":"2018","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.freeradbiomed.2017.04.368","article-title":"Non-thermal plasma induces a stress response in mesothelioma cells resulting in increased endocytosis, lysosome biogenesis and autophagy","volume":"108","author":"Shi","year":"2017","journal-title":"Free Radic Biol Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.freeradbiomed.2018.10.401","article-title":"Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: toward the era of mesothelioma prevention","volume":"133","author":"Toyokuni","year":"2019","journal-title":"Free Radic Biol Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat Rev Cancer."},{"key":"B34","doi-asserted-by":"publisher","first-page":"574","DOI":"10.21037\/tlcr.2018.04.10","article-title":"Current chemotherapy strategies in malignant pleural mesothelioma","volume":"7","author":"de Gooijer","year":"2018","journal-title":"Transl Lung Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101297","DOI":"10.1016\/j.redox.2019.101297","article-title":"Carbonic anhydrase 9 confers resistance to ferroptosis\/apoptosis in malignant mesothelioma under hypoxia","volume":"26","author":"Li","year":"2019","journal-title":"Redox Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00428-011-1178-7","article-title":"Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung","volume":"460","author":"Ramsey","year":"2012","journal-title":"Virchows Arch."},{"key":"B38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4149\/neo_2014_031","article-title":"Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study","volume":"61","author":"Capkova","year":"2014","journal-title":"Neoplasma."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: past, present and future","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Cell Death Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:07:38Z","timestamp":1574813258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":40,"alternative-id":["10.3389\/fonc.2019.01318"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01318","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"article-number":"1318"}}